Side-by-side comparison of AI visibility scores, market position, and capabilities
Financial services company with $60B revenue and $1.3T AUM; PGIM institutional asset management and pension risk transfer alongside individual life insurance and international operations.
Prudential Financial is a major American financial services company providing life insurance, retirement planning, investment management, and group insurance products to individuals and institutional clients worldwide. Listed on NYSE (NYSE: PRU) and headquartered in Newark, New Jersey, Prudential generates approximately $60 billion in annual revenue and manages over $1.3 trillion in assets under management. Founded in 1875 as The Prudential Insurance Company of America (the "Rock of Gibraltar" brand icon), Prudential has evolved from a home service life insurance company into a diversified financial services conglomerate.\n\nPrudential's key business segments include PGIM (Prudential Global Investment Management, its institutional asset management arm), US Businesses (individual life insurance, annuities, and retirement solutions), and International Businesses (life insurance and retirement products in Japan, Brazil, and other markets). PGIM is one of the top 10 largest investment managers globally with approximately $1.3 trillion AUM, managing assets for pension funds, sovereign wealth funds, and insurance companies. The US retirement business is a major provider of 401(k) plans, stable value funds, and institutional pension risk transfer.\n\nIn 2025, Prudential continues its strategic shift toward asset management and fee-based businesses and away from capital-intensive legacy insurance. The company sold its full-service retirement plan business to Empower (Great-West Life) in 2022 and has been growing PGIM and its pension risk transfer (PRT) business — taking pension liabilities off corporate balance sheets through group annuity transactions. Prudential competes with MetLife, Lincoln Financial, Principal Financial, and BlackRock for institutional retirement and insurance market share. The 2025 strategy emphasizes PGIM AUM growth, international insurance expansion in emerging markets, and pension risk transfer deal flow.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.